C-reactive protein during pregnancy and in the early postpartum predicts adverse metabolic health outcomes at 1 year postpartum in women with gestational diabetes.

"Declarations Ethics approval and concert for participateThe study protocol was approved by the Human Research Ethics Committee of the Canton de Vaud (study number 2016–00745). Consent for publicationAll participants signed an informed consent. Competing interestsAuthors declare no conflicts of interest. Competing interests Authors declare no conflicts of interest."

"Funding Open access funding provided by University of Lausanne. This study was funded by a project grant of the Swiss National Science Foundation (SNF32003B_176119) and by an unrestricted educational grant from Novo Nordisk. The SNF and Novo Nordisk had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication."